JOSE BADIA: Open Payments
NPI 1740926161 · NORTH BERGEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 58 payments from 13 companies in 2025. Trend: 2023 $1,510 · 2024 $1,792 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $280 |
| Madrigal Pharmaceuticals | 7 | $240 |
| Amgen Inc. | 7 | $118 |
| Novo Nordisk Inc | 7 | $108 |
| Aimmune Therapeutics, Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Gilead Sciences, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Exact Sciences Corporation | 1 | $25 |
Products named: REZDIFFRA, LINZESS, OTEZLA, UBRELVY, ZENPEP, JARDIANCE, CREON, Ozempic.
Industry payments across NJ — which companies pay providers there.
